Medpace increases buyback by $1.0B, expands credit line to $600M; Q1 results released without specifics

Medpace Holdings, Inc.

Board approved $1.0B increase to stock repurchase program; timing based on market conditions.
Credit facility amended: line raised to $600M, interest rate adjusted, expiration extended to April 30, 2027.
Q1 2025 earnings press release issued April 21, 2025; specific financial figures not available in this summary.
Credit facility entered with PNC Bank; Amendment No. 8 effective April 18, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.